Restalyst offered HCC-REAAD™ ERBB3 ELISA for gastric cancer surveillance study in Poland

Home
About Us
Our Products
- CANCER TESTS
- COVID-19 TESTS
Our Services
- CDMO
- Biologics Supply
What’s Happening
Contact

Home
About Us
Our Products
- Cancer Tests
- COVID-19 Tests
What’s Happening
Contact
Part of Reste Group
- Restalyst
- ResteLab

Home / Restalyst / Restalyst offered HCC-REAAD™ ERBB3 ELISA for gastric cancer surveillance study in Poland

July 11, 2019 Restalyst

Share

« Previous Post

Home
About Us
Our Products
- CANCER TESTS
- COVID-19 TESTS
Our Services
- CDMO
- Biologics Supply
What’s Happening
Contact

Contact Us

Tel: +65 6229 6025

Fax: +65 6229 6051

5 Toa Payoh West, #06-01,

Singapore 318877

© 2024 · Restalyst Pte Ltd · All Rights Reserved · Privacy Policy